Update on medicines for smoking cessation.
1Western Health, Melbourne.
Nicotine addiction is a chronic condition that can be managed with medication. First-line treatments include nicotine replacement therapy and varenicline, while bupropion is a second-line option. Electronic cigarettes show some promise but are not yet comparable to approved medications.
Area of Science:
- Addiction Medicine
- Pharmacology
- Public Health
Background:
- Nicotine addiction is a chronic, relapsing condition often persisting lifelong.
- Smoking cessation requires comprehensive strategies tailored to individual patients.
- Medication plays a crucial role in facilitating remission from nicotine dependence.
Purpose of the Study:
- To review current pharmacological interventions for smoking cessation.
- To compare the efficacy of first-line and second-line pharmacotherapies.
- To assess the role of emerging cessation aids like electronic cigarettes.
Main Methods:
- Review of existing literature on smoking cessation pharmacotherapies.
- Analysis of drug approvals and treatment guidelines.
- Comparison of quit rates across different interventions.
Main Results:
- Nicotine replacement therapy (NRT) and varenicline are established first-line treatments.
- Varenicline requires initiation prior to smoking cessation.
- Bupropion is a second-line therapy with potential risks like seizures and drug interactions.
Conclusions:
- Pharmacological interventions are essential for managing nicotine addiction.
- First-line therapies offer effective smoking cessation support.
- While electronic cigarettes show potential, their efficacy in smoking cessation is not yet equivalent to approved medications.
More Related Videos
14:21Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Drug Dependence
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Inhaled Medications
